Browse > Article
http://dx.doi.org/10.7314/APJCP.2014.15.6.2625

Serum Levels of Trace Elements in Patients with Prostate Cancer  

Kaba, Mehmet (Department of Urology, Faculty of Medicine, Yuzuncu Yil University)
Pirincci, Necip (Department of Urology, Faculty of Medicine, Yuzuncu Yil University)
Yuksel, Mehmet Bilgehan (Department of Urology, Faculty of Medicine, Celal Bayar University)
Gecit, Ilhan (Department of Urology, Faculty of Medicine, Yuzuncu Yil University)
Gunes, Mustafa (Department of Urology, Faculty of Medicine, Yuzuncu Yil University)
Ozveren, Huseyin (Department of Urology, Faculty of Medicine, Yuzuncu Yil University)
Eren, Huseyin (Department of Urology, Faculty of Medicine, Yuzuncu Yil University)
Demir, Halit (Department of Chemistry, Faculty of Science and Art, Yuzuncu Yil University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.15, no.6, 2014 , pp. 2625-2629 More about this Journal
Abstract
Background: Trace elements are major components of biological structures; however, excessive levels of these elements can be toxic. Materials and Methods: In the present study, serum levels of trace elements were measured in 30 patients with newly diagnosed as prostate cancer and 32 healthy volunteer by using furnace atomic absorption spectrophotometry. Results: It was found that there was an increase in serum levels of Co, Cu, Mg and Pb (p<0.05), whereas a decrease in serum levels of Fe, Mn, and Zn levels in patients with prostate cancer (p<0.05). Conclusions: These changes may be important in the pathogenesis of prostate cancers; however, further prospective studies are needed to identify relationships between prostate cancer and trace elements.
Keywords
Prostate cancer; trace element; patient serum levels;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
연도 인용수 순위
1 Yaman M, Kaya G, Simsek M (2007). Comparision of trace elements concentrations in cancerous and noncancerous human endometrial and ovary tissues. Int J Gynecol Cancer, 17, 220-8.   DOI   ScienceOn
2 Waisberg M, Joseph P, Hale B, Beyersmann D (2003). Molecular and cellular mechanisms of cadmium carcinogenesis. Toxicology, 192, 95-117.   DOI   ScienceOn
3 Wijngaarden EV, Dosemeci M (2006). Brain cancer mortality and potential occupational exposure to lead: findings from the National Longitudinal Mortality Study, 1979-1989. Int J Cancer, 119, 1136-44.   DOI   ScienceOn
4 Wu T, Sempos CT, Freudenheim JL, Muti P, Smit E (2004). Serum iron, copper and zinc concentrations and risk of cancer mortality in US adults. Ann Epidemiol, 14, 195-201.   DOI   ScienceOn
5 Yaman M, Atici D, Bakirdere S, Akdeniz I. (2005). Comparison of trace metal concentrations in malign and benign human prostate. J Med Chem, 48, 630-4.   DOI   ScienceOn
6 Zacharski LR, Chow BK, Howes PS, et al (2008). Decreased cancer risk after iron reduction in patients with peripheral arterial disease: Results from a randomized trial. J Natl Cancer Inst, 100, 996-1002.   DOI   ScienceOn
7 Zowczak M, Iskra M, Torlinski L, Cofta S (2001). Analysis of serum copper and zinc concentration in cancer patients. Biol Trace Elem Res, 82, 1-8.   DOI   ScienceOn
8 Nawrot TS, Thijs L, Den Hond EM, Roels HA, Staessen JA (2002). An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens, 16, 123-31.   DOI   ScienceOn
9 Piccinini L, Borella P, Bargellini A, Medici CI, Zoboli A (1996). A case- control study on selenium, zinc, and copper in plasma and hair of subjects affected by breast and lung cancer. Biol Trace Element Res, 51, 23-30.   DOI   ScienceOn
10 Pirincci N, Gecit I, Gunes M, et al (2013). Levels of serum trace elements in renal cell carcinoma cases. Asian Pac J Cancer Prev, 14, 499-502.   DOI   ScienceOn
11 Sayir F, Kavak S, Meral I, Demir H, Cengiz N, Cobanoglu U (2013). Effects of crush and axotomy on oxidative stress and some trace element levels in phrenic nerve of rats. Brain Res Bull, 92, 84-8.   DOI   ScienceOn
12 Theophanides T, Anastassopoulou J (2002). Copper and carcinogenesis. Crit Rev Oncol Hematol, 42, 57-64.   DOI   ScienceOn
13 Tokar EJ, Diwan BA, Waalkes MP (2010). Early life inorganic lead exposure induces testicular teratoma and renal and urinary bladder preneoplasia in adult metallothioneinknockout mice but not in wild type mice. Toxicology, 276, 5-10.   DOI   ScienceOn
14 Turecky L, Kalina P, Uhlikova E, Namerova S, Krizko J (1984). Serum ceruloplasmin and copper levels in patients with primary brain tumors. Klin Wochenschr, 62, 187-9.   DOI   ScienceOn
15 Mainous AG, Wells BJ, Koopman RJ, Everett CJ, Gill JM (2005). Iron, lipids, and risk of cancer in the framingham offspring cohort. Am J Epidemiol, 161, 1115-22.   DOI   ScienceOn
16 Uauy R, Olivares M, Gonzalez M (1998). Essentiality of copper in humans. Am J Clin Nutr, 67, 952-9.
17 Vinceti M, Venturelli M, Sighinolfi C, et al (2007). Case-control study of toenail cadmium and prostate cancer risk in Italy. Sci Total Environ, 373, 77-8.   DOI   ScienceOn
18 Waalkes MP (2003). Cadmium carcinogenesis. Mutat Res, 533, 107-20.   DOI   ScienceOn
19 Kuvibidila S, Gauthier T, Warrier RR, Rayford W (2004). Increased levels of serum ferritin receptor and serum transferring receptor/log ferritin ratios in men with prostate cancer and the implications for body-iron stores. J Lab Clin Med, 144, 176-82.   DOI   ScienceOn
20 Mahata J, Basu A, Ghoshal S, et al (2003). Chromosomal aberrations and sister chromatid exchanges in individuals exposed to arsenic through drinking water in West Bengal, India. Mutat Res, 534, 133-43.   DOI   ScienceOn
21 Majumder S, Chatterjee S, Pal S, et al (2009). The role of copper in drug-resistant murine and human tumors. Biometals, 22, 377-84.   DOI
22 Michalaki V, Syrigos K, Charles P, Waxman J (2004) Serum levels of IL-6 and TNF-alpha correlate with clinicopathological features and patient survival in patients with prostate cancer. Br J Cancer, 90, 2312-6.
23 Mori H, Morishita Y, Mori Y, et al (1992). Effect of magnesium hydroxide on methylazoxymethanol acetate- induced epithelial proliferation in the largebowels of rats. Cancer Lett, 62,43-8.   DOI   ScienceOn
24 Goyer RA, Liu J, Waalkes MP (2004). Cadmium and cancer of prostate and testis. Biometals, 17, 555-8.   DOI   ScienceOn
25 Naga Raju GJ, Sarita P, Ramana Murty GA, et al (2006). Estimation of trace elements in some anti-diabetic medicinal plants using PIXE technique. Appl Radiat Isot, 64, 893-900.   DOI   ScienceOn
26 Nakamura K, Yasunaga Y, Ko D, et al (2002). Cadmium-induced neoplastic transformation of human prostate epithelial cells. Int J Oncol, 20, 543-47.
27 Gyorkey F, Min KW, Huff JA, Gyorkey P (1967). Zinc and magnesium in human prostate gland: normal, hyperplastic, and neoplastic. Cancer Res, 27, 1348-53.
28 Gronberg, H (2003). Prostate cancer epidemiology. Lancet, 361, 859-64.   DOI   ScienceOn
29 Guntupalli JN, Padala S, Gummuluri AV, et al (2008). Trace elemental analysis of normal, benign hypertrophic and cancerous tissues of the prostate gland using the particleinduced X-ray emission technique. Eur J Cancer Prev, 16, 108-15.
30 Harris GK, Shi X (2003). Signaling by carcinogenic metals and metal-induced reactive oxygen species. Mutat Res, 533, 183-200.   DOI   ScienceOn
31 Inskip PD, Linet MS, Heineman EF (1995). Etiology of brain tumors in adults. Epidemiol Rev, 17, 382-414.
32 Jemal A, Siegel R, Ward E, et al (2007). Cancer statistics. CA Cancer J Clin, 57, 43-66.   DOI   ScienceOn
33 Jarup L (2003). Hazards of heavy metal contamination. Br Med Bull, 68, 167-82.   DOI   ScienceOn
34 Karimi G, Shahar S, Homayouni N, et al (2012). Association between trace element and heavy metal levels in hair and nail with prostate cancer. Asian Pac J Cancer Prev, 13, 4249-53.   DOI   ScienceOn
35 El-Serag HB, Mason AC (2000). Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med, 160, 3227-30.   DOI   ScienceOn
36 Killilea AN, Downing KH, Killilea DW.(2007). Zinc deficiency reduces paclitaxel efficacy in LNCaP prostate cancer cells. Cancer Lett, 258, 70-9.   DOI   ScienceOn
37 Knekt P, Reunanen A, Takkunen H et al (1994). Body iron stores and risk of cancer. Int J Cancer, 56, 379-82.   DOI   ScienceOn
38 Eisenstein RS (2000). Iron regulatory proteins and the molecular control of mammalian iron metabolism. Annu Rev Nutr, 20, 627-62.   DOI   ScienceOn
39 Ganz T, Nemeth E (2006). Iron imports. IV. Hepcidin and regulation of body iron metabolism. Am J Physiol Gastrointest Liver Physiol, 290, 199-203.   DOI   ScienceOn
40 Gecit I, Kavak S, Demir H, et al (2011). Serum trace element levels in patients with bladder cancer. Asian Pac J Cancer Prev, 12, 3409-13.
41 George DJ, Halabi S, Shepard TF, et al (2005). The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: Results from cancer and leukemia group B 9480. Clin Cancer Res, 11, 1815-20.   DOI   ScienceOn
42 Geraki K, Farquharson MJ, Bradley DA (2002). Concentrations of Fe, Cu and Zn in breast tissue: a synchrotron XRF study. Phys Med Biol , 47, 2327-39.   DOI   ScienceOn
43 Geraki K, Farquharson MJ, Bradley DA (2004). X-ray fluorescence and energy dispersive x-ray diffraction for the quantification of elemental concentrations in breast tissue. Phys Med Biol, 49, 99-110.   DOI   ScienceOn
44 Geraki K, Farquharson MJ, Bradley DA, Hugtenburg RP (2004). Nucl Instrum Methods Phys Res B, 213, 564-8.   DOI   ScienceOn
45 Andrews NC (2008). Forging a field: the golden age of iron biology. Blood, 112, 219-30.   DOI   ScienceOn
46 Banas A, Kwiatek WM, Banas K, et al (2010). Correlation of concentrations of selected trace elements with Gleason grade of prostate tissues. J Biol Inorg Chem, 15, 1147-55.   DOI
47 Arslan M, Demir H, Arslan H, Gokalp AS, Demir C (2011). Trace elements, heavy metals and other biochemical parameters in malignant glioma patients. Asian Pac J Cancer Prev, 12, 447-51.
48 Achanzar WE, Diwan BA, Liu J, et al (2001). Cadmium-induced malignant transformation of human prostate epithelial cells. Cancer Res, 61, 455-8.
49 Arredondo M, Nunez MT (2005). Iron and copper metabolism. Mol Aspects Med, 26, 313-27.   DOI   ScienceOn
50 Brys M, Nawrocka AD, Miekos E, et al (1997). Zinc and cadmium analysis in human prostate neoplasms. Biol Trace Elem Res, 59, 145-52.   DOI   ScienceOn
51 Collery P, Anghileri LJ, Coudoux P, et al (1981). Magnesium and cancer: clinical data. Magnesium Bull, 3, 11-20.
52 Costello LC, Franklin RB (1998). Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer. Prostate, 35, 285-96.   DOI
53 Costello LC, Franklin RB, Narayan P (1999). Citrate in the diagnosis of prostate cancer. Prostate, 38, 237-45.   DOI
54 Cunzhi H, Jiexian J, Xianwen Z, et al (2003). Serum and tissue levels of six trace elements and copper/zinc ratio in patients with cervical cancer and uterine myoma. Biol Trace Elem Res, 94, 113-22.   DOI   ScienceOn
55 Costello LC, Liu Y, Zou J, Franklin RB (1999). Evidence for a zinc uptake transporter in human prostate cancer cell which is regulated by prolaction and testosterone. J Biol Chem. 274, 17499-504.   DOI
56 Reddy MB, Clark L (2004). Iron, oxidative stress, and disease risk. Nutr Rev, 62, 120-4.   DOI
57 Lindegaard PM, Hansen SO, Christensen JE, Andersen BB, Andersen O (1990). The distribution of cadmium within the human prostate. Biol Trace Elem Res, 25, 97-104.   DOI
58 Hartwig A (2010). Mechanisms in cadmium-induced carcinogenicity: recent insights. Biometals, 23, 951-60   DOI
59 Gecit I, Kavak S, Meral I, et al (2011). Effects of shock waves on oxidative stress, antioxidant enzyme and element levels in kidney of rats. Biol Trace Elem Res, 144, 1069-76.   DOI   ScienceOn